A 26-year-old woman who is a medical student is undergoing evaluation after sticking herself with a needle while drawing blood from a patient. The patient’s medical history is unknown. A blood sample from the medical student is drawn and processed, and the results are presented below: Anti-HAV IgM negative Anti-HAV IgG positive HBsAg negative HBeAg negative Anti-HBs negative Anti-HBc IgG negative Anti-HBc IgM negative Anti-HBe negative Anti-HCV negative What is true about the student’s laboratory findings?

She has not been vaccinated against the hepatitis B virus.

She recovered from a hepatitis B virus infection.

She is infected with the hepatitis D virus.

She can transmit the hepatitis A virus.

She is an asymptomatic carrier of the hepatitis B virus.

A 52-year-old female presents to her primary care physician for medical evaluation prior to an elective hip replacement surgery. She has hypertension and diabetes, both of which are well controlled on oral medications. She also admits to occasional use of recreational injection drugs so a panel of serologies are obtained. Based on the results, the patient is found to have had a previous infection with hepatitis B from which she has fully recovered. Which of the following is a characteristic of the immunoglobulin subtype that most likely binds to hepatitis B core antigen in this patient?

It is only activated by multivalent immunogens

A 44-year-old woman presents to the emergency department with jaundice and diffuse abdominal pain. She denies any previous medical problems and says she does not take any medications, drugs, or supplements. Her temperature is 97.6°F (36.4°C), blood pressure is 133/87 mmHg, pulse is 86/min, respirations are 22/min, and oxygen saturation is 100% on room air. Physical exam is notable for sclera which are icteric and there is tenderness to palpation over the right upper quadrant. Laboratory studies are ordered as seen below. Hepatitis B surface antigen: Positive Hepatitis B surface antibody: Negative Hepatitis B core antibody IgM: Negative Hepatitis B core antibody IgG: Positive Hepatitis B E antigen: Positive Hepatitis B E antibody (anti-HBe): Negative Which of the following is the most likely diagnosis?

No hepatitis B vaccination or infection

A 47-year-old woman comes to the physician because of a 3-week history of generalized fatigue, mild fever, abdominal pain, and nausea. She attended the state fair over a month ago, where she tried a number of regional foods, and wonders if it might have been caused by something she ate. She has also noticed darkening of her urine, which she attributes to not drinking enough water recently. She has type 2 diabetes mellitus. She drinks 1–2 beers daily. She works as nursing assistant in a rehabilitation facility. Current medications include glyburide, sitagliptin, and a multivitamin. She appears tired. Her temperature is 38.1°C (100.6°F), pulse is 99/min, and blood pressure is 110/74 mm Hg. Examination shows mild scleral icterus. The liver is palpated 2–3 cm below the right costal margin and is tender. Laboratory studies show: Hemoglobin 10.6 g/dL Leukocyte count 11600/mm3 Platelet count 221,000/mm3 Serum Urea nitrogen 26 mg/dL Glucose 122 mg/dL Creatinine 1.3 mg/dL Bilirubin 3.6 mg/dL Total 3.6 mg/dL Direct 2.4 mg/dL Alkaline phosphatase 72 U/L AST 488 U/L ALT 798 U/L Hepatitis A IgG antibody (HAV-IgG) positive Hepatitis B surface antigen (HBsAg) positive Hepatitis B core IgG antibody (anti-HBc) positive Hepatitis B envelope antigen (HBeAg) positive Hepatitis C antibody (anti-HCV) negative Which of the following is the most likely diagnosis?

Active chronic hepatitis B infection

Resolved acute hepatitis B infection

Inactive chronic hepatitis B infection

A 32-year-old woman comes to the emergency department for a 2-week history of right upper quadrant abdominal pain. She has also been feeling tired and nauseous for the past 5 weeks. She has a history of depression and suicidal ideation. She is a social worker for an international charity foundation. She used intravenous illicit drugs in the past but quit 4 months ago. Her only medication is sertraline. Her temperature is 37.8°C (100.0°F), pulse is 100/min, and blood pressure is 128/76 mm Hg. She is alert and oriented. Scleral icterus is present. Abdominal examination shows tenderness to palpation in the right upper quadrant. The liver edge is palpated 3 cm below the right costal margin. There is no rebound tenderness or guarding. The abdomen is non-distended and the fluid wave test is negative. She is able to extend her arms with wrists in full extension and hold them steady without flapping. Laboratory studies show: Hemoglobin 13.8 g/dL Leukocytes 13,700/mm3 Platelets 165,000/mm3 Prothrombin time 14 seconds Partial thromboplastin time 35 seconds Serum: Total bilirubin 4.8 mg/dL Direct bilirubin 1.3 mg/dL Aspartate aminotransferase 1852 U/L Alanine aminotransferase 2497 U/L Urea nitrogen 21 mg/dL Creatinine 1.2 mg/dL Hepatitis A IgM antibody Negative Hepatitis B surface antigen Negative Hepatitis B surface antibody Negative Hepatitis B core IgM antibody Positive Hepatitis C antibody Positive Hepatitis C RNA Negative Urine beta-hCG Negative Which of the following is the most appropriate next step in management?

Vaccination against Hepatitis B

Chronic hepatitis B phases for USMLE Step 1: High-Yield Microbiology Lessons

Chronic Hep B - A Phased Journey

Chronic HBV infection is a dynamic process, with distinct phases defined by the interplay between viral replication and the host immune response. Not all patients go through all phases, and transitions can occur.

1. Immune Tolerant:
- High HBV DNA (>1,000,000 IU/mL), Normal ALT.
- HBeAg positive; minimal inflammation.
2. Immune Active (HBeAg-positive):
- ↓ HBV DNA, but >20,000 IU/mL; ↑ ALT.
- Active inflammation & fibrosis progression.
⭐ This phase carries the highest rate of progression to cirrhosis and hepatocellular carcinoma (HCC).
3. Inactive Carrier State:
- Low/undetectable HBV DNA (<2,000 IU/mL), Normal ALT.
- HBeAg negative, Anti-HBe positive.
4. Reactivation (HBeAg-negative):
- ↑ HBV DNA (>2,000 IU/mL), ↑ ALT.
- Spontaneous or due to immunosuppression.

Phase Breakdown - The Viral Showdown

This table outlines the dynamic phases of chronic HBV infection, defined by the interplay between viral replication and the host immune response. Progression through these phases is not always linear.

Chronic Hepatitis B Phases: Serology and ALT Levels

Phase	HBeAg	Anti-HBe	HBV DNA (IU/mL)	ALT	Liver Histology
1. Immune Tolerant	+	-	Very High (>1,000,000)	Normal	Minimal inflammation/fibrosis
2. Immune Active	+	-	High (>20,000)	↑	Active inflammation, fibrosis progression
3. Inactive Carrier	-	+	Low (<2,000) or Undetectable	Normal	Minimal inflammation, variable fibrosis
4. HBeAg-Negative Reactivation	-	+	High (>2,000)	↑	Active inflammation, fibrosis progression

Immune Active (HBeAg-Positive): The immune system starts to recognize and attack infected hepatocytes, causing liver inflammation (↑ ALT) and damage.
Inactive Carrier: Occurs after HBeAg seroconversion. Viral replication is low and controlled by the immune system.
HBeAg-Negative Reactivation: Virus mutates (pre-core/basal core promoter) to replicate without producing HBeAg. Immune response resumes, causing inflammation.

⭐ Exam Favorite: The highest risk of progression to cirrhosis and hepatocellular carcinoma (HCC) occurs during the Immune Active and HBeAg-Negative Reactivation phases due to persistent necroinflammation.

High‑Yield Points - ⚡ Biggest Takeaways

Immune tolerant phase: HBeAg-positive with very high HBV DNA but normal ALT; minimal liver damage.

Immune active phase: Marked by elevated ALT, high HBV DNA, and active liver inflammation driving fibrosis.

Inactive carrier state: HBeAg-negative/anti-HBe positive with low HBV DNA (<2,000 IU/mL) and normal ALT.

Reactivation (HBeAg-negative hepatitis): Features elevated ALT and HBV DNA >2,000 IU/mL despite HBeAg loss.

Risk of cirrhosis/HCC is highest during the immune active and reactivation phases.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play